Studies Showing Incorrect Potency 28
Studies Showing Lack of Stability 31
Studies Showing Lack of Efficacy 31
Risks Associated with Specific Types of Compounds 32
Active Ingredient Source Decisions 34
Patient-Specific Compounding Versus Office Use Compounding 35
Adverse Event Reporting 36
Identifying Potential Formulation Issues 37
Drug Recalls 38
Selecting a Compounding Pharmacy 39
Client Education 40
Reducing Risk in Practice 40
Conclusion 41
CHAPTER 3. Beyond-Use Dating, pág 45
Factors Considered When Assigning BUDs and Expiration Dates 45
USP Default BUDs 48
Stability Studies 49